 |
인쇄하기
취소
|
Dong-A hikes R&D budget in 2010
Dong-A Pharmaceutical Co., Korea’s No.1 pharmaceutical firm, said it spent 8 percent of its revenue on research and development (R&D) last year, up 0.6 percentage points from R&D budget in 2010.
“The increasing investment in R& D is one of measures to transform Dong-A into an inventor of rolling out new drugs,” said a company official.
“Based on the results of our R& D efforts last year, ...
“The increasing investment in R& D is one of measures to transform Dong-A into an inventor of rolling out new drugs,” said a company official.
“Based on the results of our R& D efforts last year, ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.